Lung cancer is the third most common cancer in the UK, with around 47,200 people diagnosed each year. There are two main types of lung cancer – small-cell lung cancer and non-small-cell lung cancer – depending on how the cells look under the microscope.
The main symptoms are a cough, shortness of breath and weight loss.
New data suggest that targeted therapy seems to be having an impact on the treatment of lung cancer.
The National Lung Matrix Trial – a £25 million collaboration with pharmaceutical companies and the NHS – has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.
Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.
Scientists working on the TRACERx project have mapped how the immune systems responds to lung tumours over time
New research reveals how some cancer cells double their genome to help them survive. Find out more about cancer’s ‘spare tyre’.
Inflammation can prevent infections and helps repair injuries. But for people with long-term inflammatory conditions, it can sometimes lead to cancer.
Scientists are taking a leaf out of Darwin’s evolutionary handbook to understand how lung cancer evolves.
The roll-out of mobile NHS scanners will save lives from lung cancer. But staff shortages, stop smoking services and treatment inequalities can’t be ignored.
Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening.